‘Collateral’ lethality may offer new therapeutic approach for cancers of the pancreas, stomach and colon

Heard of collateral lethality? It’s a therapeutic strategy that uses gene deletions with no direct role in the tumor progression. A recent study published in Science Daily shows how scientists discovered that this process can be used in novel therapy approaches for gastric cancer.